Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection

The introduction of biologic drugs revolutionized the management of moderate-to-severe forms of psoriasis. However, safety concerns still remain, particularly on patient affected by opportunistic infections. In this scenario, the safety of biologic drugs in patient with HBV infection is debated. Glo...

Descripción completa

Detalles Bibliográficos
Autores principales: Potestio, Luca, Piscitelli, Ilaria, Fabbrocini, Gabriella, Martora, Fabrizio, Ruggiero, Angelo, Megna, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911898/
https://www.ncbi.nlm.nih.gov/pubmed/36776245
http://dx.doi.org/10.2147/CCID.S403294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911898/
https://www.ncbi.nlm.nih.gov/pubmed/36776245
http://dx.doi.org/10.2147/CCID.S403294

Ejemplares similares